naltrexone and midazolam

naltrexone has been researched along with midazolam in 31 studies

Research

Studies (31)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	12 (38.71)	18.2507
2000's	12 (38.71)	29.6817
2010's	6 (19.35)	24.3611
2020's	1 (3.23)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Dalvie, D; Loi, CM; Smith, DA	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Lenz, K; Loimer, N; Presslich, O; Schmid, R	2
Fujimoto, JM; Rady, JJ	1
Gossop, M; Legarda, JJ	1
Bellgowan, PS; Helmstetter, FJ	1
Chang, KJ; Comer, SD; De Costa, BR; Hoenicke, EM; McNutt, RW; Mosberg, HI; Sable, AI; Woods, JH	1
Chaudhry, H; Hofmann, P; Loimer, N	1
Gent, JP; Goodchild, CS; Guo, Z; Musgreave, A	1
Brandt, MR; France, CP; Gerak, LR	1
Collins, PD; Cook, TM	1
Bertschy, G; Cucchia, AT; Ferrero, F; Monnat, M; Spagnoli, J	1
Avanzi, V; Brandão, ML; Castilho, VM	1
Burns, MM; Chumpa, A; Kaplan, RL; Shannon, MW	1
Brandão, ML; Castilho, VM; Macedo, CE	1
Folk, JE; Isgor, C; Rice, KC; Torregrossa, MM; Watson, SJ; Woods, JH	1
Spelman, LH	1
Adams, M; Ahdieh, H; Gammaitoni, AR; Pieniaszek, HJ	1
Brandão, ML; De Luca-Vinhas, MC; Macedo, CE	1
Becker, GL; France, CP; Gerak, LR; Li, JX; McMahon, LR	1
Hayek, LC; Marker, L; Murray, S; Sanchez, CR; Woc Colburn, AM	1
Costello, MA; Farrell, AP; Fuller, A; Haw, A; Izwan, A; Maloney, SK; Meyer, LCR; Mitchell, D; Seymour, RS; Snelling, EP	1
Gardner, BR; Kotze, PGH; McCue, SA; Musson, M; Seakamela, SM; Spolander, B	1

Reviews

1 review(s) available for naltrexone and midazolam

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

3 trial(s) available for naltrexone and midazolam

Article	Year
Nalmefene for elective reversal of procedural sedation in children. The American journal of emergency medicine, 2001, Volume: 19, Issue:7 Topics: Analgesics, Opioid; Anesthetics, Intravenous; Antidotes; Child; Child, Preschool; Emergency Medical Services; Female; Fentanyl; Humans; Infant; Male; Midazolam; Naltrexone; Narcotic Antagonists	2001
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways. Journal of clinical pharmacology, 2005, Volume: 45, Issue:3 Topics: Adolescent; Adult; Analgesics, Opioid; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Interactions; Erythromycin; Female; Humans; Male; Midazolam; Middle Aged; Naltrexone; Oxymorphone; Rifampin; Tolbutamide	2005
CARDIORESPIRATORY EFFECTS OF DEXMEDETOMIDINE-BUTORPHANOL-MIDAZOLAM (DBM): A FULLY REVERSIBLE ANESTHETIC PROTOCOL IN CAPTIVE AND SEMI-FREE-RANGING CHEETAHS (ACINONYX JUBATUS). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2017, Volume: 48, Issue:1 Topics: Acinonyx; Analgesics, Opioid; Anesthesia; Animals; Animals, Zoo; Butorphanol; Dexmedetomidine; Drug Therapy, Combination; Female; Heart Rate; Hypnotics and Sedatives; Imidazoles; Male; Midazolam; Naltrexone; Respiration	2017

Other Studies

27 other study(ies) available for naltrexone and midazolam

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Which metabolites circulate? Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5 Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations	2013
Rapid transition from methadone maintenance to naltrexone. Lancet (London, England), 1990, Jan-13, Volume: 335, Issue:8681 Topics: Flumazenil; Humans; Methadone; Midazolam; Naltrexone; Substance Withdrawal Syndrome	1990
Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. The American journal of psychiatry, 1991, Volume: 148, Issue:7 Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methadone; Midazolam; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome	1991
Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice. Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:2 Topics: Analgesics; Animals; Clonidine; Dose-Response Relationship, Drug; Dynorphins; GABA Antagonists; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Midazolam; Morphine; Naloxone; Naltrexone; Pain Measurement; Reaction Time; Spinal Cord	1993
A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug and alcohol dependence, 1994, Volume: 35, Issue:2 Topics: Administration, Oral; Adult; Conscious Sedation; Drug Administration Schedule; Follow-Up Studies; Guanfacine; Heroin Dependence; Humans; Intensive Care Units; Length of Stay; Male; Midazolam; Naltrexone; Neurologic Examination; Patient Admission; Premedication; Substance Abuse Detection; Substance Withdrawal Syndrome	1994
Hypoalgesia in response to sensitization during acute noise stress. Behavioral neuroscience, 1994, Volume: 108, Issue:1 Topics: Acoustic Stimulation; Animals; Arousal; Association Learning; Attention; Conditioning, Classical; Fear; Loudness Perception; Male; Midazolam; Naltrexone; Nociceptors; Noise; Pain Threshold; Rats; Reaction Time; Receptors, Opioid; Tail; Thermosensing	1994
Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2 Topics: Amino Acid Sequence; Animals; Anticonvulsants; Benzamides; Dose-Response Relationship, Drug; Drug Tolerance; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalins; Kindling, Neurologic; Male; Mice; Mice, Inbred Strains; Midazolam; Molecular Sequence Data; Naltrexone; Pentylenetetrazole; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, mu; Seizures	1993
Ultrashort noninvasive opiate detoxification. The American journal of psychiatry, 1993, Volume: 150, Issue:5 Topics: Adult; Heroin Dependence; Humans; Male; Midazolam; Naloxone; Naltrexone; Ondansetron; Substance Withdrawal Syndrome; Time Factors	1993
Antinociception by intrathecal midazolam involves endogenous neurotransmitters acting at spinal cord delta opioid receptors. British journal of anaesthesia, 1996, Volume: 77, Issue:6 Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Midazolam; Naltrexone; Narcotic Antagonists; Nociceptors; Pain Measurement; Pain Threshold; Rats; Receptors, Opioid; Receptors, Opioid, delta; Spinal Cord	1996
Studies on benzodiazepines and opioids administered alone and in combination in rhesus monkeys: ventilation and drug discrimination. Psychopharmacology, 1998, Volume: 137, Issue:2 Topics: Animals; Benzodiazepines; Discrimination Learning; Dose-Response Relationship, Drug; Drug Synergism; Female; Flumazenil; Macaca mulatta; Male; Midazolam; Morphine; Naltrexone; Narcotics; Respiration	1998
Rapid opioid detoxification under anaesthesia. Hospital medicine (London, England : 1998), 1998, Volume: 59, Issue:3 Topics: Adult; Anesthesia, General; Atracurium; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Agents; Humans; Hypnotics and Sedatives; Male; Midazolam; Naloxone; Naltrexone; Narcotic Antagonists; Nicotinic Antagonists; Octreotide; Opioid-Related Disorders; Propofol	1998
Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. Drug and alcohol dependence, 1998, Nov-01, Volume: 52, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Anesthesia, General; Clonidine; Drug Therapy, Combination; Feasibility Studies; Female; Follow-Up Studies; Heroin Dependence; Humans; Hypnotics and Sedatives; Length of Stay; Male; Methadone; Midazolam; Naltrexone; Narcotic Antagonists; Neurologic Examination; Ondansetron; Substance Withdrawal Syndrome; Treatment Outcome	1998
Antinociception elicited by aversive stimulation of the inferior colliculus. Pharmacology, biochemistry, and behavior, 1999, Volume: 62, Issue:3 Topics: Algorithms; Analgesia; Animals; Arousal; Behavior, Animal; Electric Stimulation; Escape Reaction; GABA Modulators; Inferior Colliculi; Ketanserin; Male; Methysergide; Midazolam; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Wistar; Serotonin Antagonists; Stress, Psychological	1999
Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats. Psychopharmacology, 2002, Volume: 165, Issue:1 Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Benzodiazepines; Conditioning, Classical; Dose-Response Relationship, Drug; Electric Stimulation; Escape Reaction; Male; Methysergide; Microinjections; Midazolam; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Periaqueductal Gray; Rats; Rats, Wistar; Reaction Time; Serotonin; Serotonin Antagonists	2002
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:4 Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Benzamides; Brain; Brain-Derived Neurotrophic Factor; Bupropion; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Gene Expression Regulation; Immobilization; In Situ Hybridization; Male; Midazolam; Naltrexone; Narcotic Antagonists; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, Opioid, delta; RNA, Messenger; Swimming; Time Factors; Up-Regulation	2004
Reversible anesthesia of captive California sea lions (Zalophus californianus) with medetomidine, midazolam, butorphanol, and isoflurane. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2004, Volume: 35, Issue:1 Topics: Anesthetics, Combined; Anesthetics, Inhalation; Animals; Antidotes; Butorphanol; Dose-Response Relationship, Drug; Female; Flumazenil; Heart Rate; Hypnotics and Sedatives; Imidazoles; Immobilization; Isoflurane; Medetomidine; Midazolam; Naltrexone; Narcotic Antagonists; Narcotics; Respiration; Sea Lions; Time Factors	2004
Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray. Pain, 2006, Volume: 121, Issue:1-2 Topics: Analysis of Variance; Anesthetics, Intravenous; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Exploratory Behavior; Freezing Reaction, Cataleptic; Ketanserin; Male; Microinjections; Midazolam; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Pain Measurement; Pain Threshold; Periaqueductal Gray; Rats; Rats, Wistar; Reaction Time; Serotonin Antagonists	2006
Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception. Psychopharmacology, 2008, Volume: 199, Issue:2 Topics: Analgesics; Analgesics, Opioid; Animals; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Heroin; Hot Temperature; Hypnotics and Sedatives; Macaca mulatta; Male; Midazolam; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, mu; Substance Withdrawal Syndrome	2008
Ameliorating the adverse cardiorespiratory effects of chemical immobilization by inducing general anaesthesia in sheep and goats: implications for physiological studies of large wild mammals. Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology, 2018, Volume: 188, Issue:6 Topics: Analgesics, Opioid; Anesthesia, General; Anesthetics, Intravenous; Animals; Animals, Wild; Azaperone; Etorphine; Goats; Hemodynamics; Hypnotics and Sedatives; Immobilization; Midazolam; Naltrexone; Narcotic Antagonists; Propofol; Respiration; Sheep	2018
Disentanglement of Cape fur seals (Arctocephalus pusillus pusillus) with reversible medetomidine-midazolam-butorphanol. Journal of the South African Veterinary Association, 2021, May-21, Volume: 92, Issue:0 Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Butorphanol; Conscious Sedation; Drug Combinations; Fur Seals; Hypnotics and Sedatives; Imidazoles; Medetomidine; Midazolam; Naltrexone; Narcotic Antagonists	2021